Donate For Public and Patients Store Search

W006 - Hands-on: Lasers

Monday, March 4; 1:00 PM - 4:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Discuss current indications and treatment protocols for laser and light treatments including vascular, tattoo, pigment, nonablative, fractional, and ablative lasers.
  • Identify appropriate patients and gain treatment pearls for skin tightening, fat melting, and body contouring procedures.
  • Utilize proper laser techniques, and treat a variety of dermatologic conditions with laser and light devices.


This session is geared toward all levels of dermatologists, from beginner and intermediate to advanced levels. It offers small groups, hands-on experience practicing a variety of laser skills and techniques. Approaches to patient assessment and selection, treatment planning, equipment selection, laser safety, and proper application of devices will be covered. Small groups will rotate between stations demonstrating ablative resurfacing, nonablative rejuvenation, tattoo and pigment removal, acne and vascular lesions, skin tightening, fat melting, and body contouring. Participants will complete a pre- and post-assessment of procedural skills covered in this session. This activity has been approved by the American Board of Dermatology (ABD) for up to 30 MOC Component 2 Self-Assessment points. For more information about MOC, please visit the ABD website at


  • Avram, Mathew M., MD, JD: Alastin Skincare, Inc – C(Fees); Allergan, Inc – C(Fees); Cytrellis Biosystems, Inc – C(ST); Invasix – C(Fees); Masters of Aesthetics, Inc. – F(Fees); Merz Aesthetics – C(Fees); Sciton Inc. – A(Fees); Sienna Biopharmaceuticals – A(Fees); Zalea, LLC – C(Fees); Zeltiq Aesthetics – C(Fees);
  • Bernstein, Eric F., MD: Candela Corporation – A(Fees), A(SO); Syneron, Inc. – I(Grants/Research Funding); Zeltiq Aesthetics – A(H);
  • Champlain, Amanda Hope, MD: no financial relationships exist with commercial interests.
  • DiGiorgio, Catherine M, MD, MS: no financial relationships exist with commercial interests.
  • Green, Jeremy, MD: Aclaris Therapeutics Inc. – A(H); Allergan, Inc – A(H), I(Grants/Research Funding), SP(H); Bonti – A(H); Brickell Biotech, Inc. – I(Grants/Research Funding); Candesant Biomedical, Inc. – I(Grants/Research Funding), SH(ST); Clarisonic – A(H); Cutera, Inc. – SP(H); Cynosure, Inc. – SP(EQ); Endo International plc – A(H); Evolus, Inc. – A(H); Galderma Laboratories, L.P. – I(Grants/Research Funding), SP(H); Galderma USA – A(H); Lutronic – I(Grants/Research Funding); Merz Aesthetics – A(H), I(Grants/Research Funding), SP(H); Pulse Biosciences – I(Grants/Research Funding); Revance Therapeutics, Inc. – A(H), I(Grants/Research Funding); Sienna Labs, Inc. – A(H), I(Grants/Research Funding);
  • Kelly, Kristen Marie, MD: Allergan, Inc – C(H), I(Grants/Research Funding); Asclepion Laser Technologies GmbH – O(EQ); Candela Corporation – O(EQ), O(NC); New Star Lasers – I(EQ); R2 Dermatology, Inc. – I(EQ); Reliant Technologies, Inc. – O(EQ); Sciton, Inc. – C(H), SP(H); Shanghai Fudan-Zhangjiang Bio Pharmaceutical Co., Ltd. – C(H); Thermage – O(EQ); Vivosight – C(EQ);
  • Kilmer, Suzanne L., MD: Aesthetics Biomedical – I(H); Alastin Skincare, Inc – I(H); Allergan, Inc – I(Grants/Research Funding); BTL Industries – A(Grants/Research Funding); Cutera, Inc. – I(Grants/Research Funding); Cynosure, Inc. – I(Grants/Research Funding); Cytrellis Biosystems, Inc – A(Grants/Research Funding); Dominion Aesthetics – I(H); Galderma USA – A(H); Lumenis – I(Grants/Research Funding); Lutronics, Inc. – I(Grants/Research Funding); Merz Aesthetics – I(Grants/Research Funding); Miramar Labs – A(H); Pulse Biosciences – A(Grants/Research Funding); R2 Dermatology, Inc. – I(Grants/Research Funding); Sciton Inc. – A(Grants/Research Funding); Sienna Labs, Inc. – A(H); Solta Medical – I(Grants/Research Funding); Syneron Candela – A(Grants/Research Funding);
  • Lee, Kachiu Cecilia, MD, MPH: no financial relationships exist with commercial interests.
  • Levin, Yakir S, MD, PhD: Blossom Innovations, LLC – C(NC); Gilead Sciences – SH(NC);
  • Onwudiwe, Oge C., MD: no financial relationships exist with commercial interests.
  • Ortiz, Arisa, MD: Aerolase – A(H), O(EQ); Alastin Skincare, Inc – C(H); Allergan, Inc – A(H), SH(NC), SP(H); BTL Industries – O(EQ); Cutera, Inc. – C(H); Guthy-Renker – SP(S); InMode MD Ltd – A(H), SP(H); Merz Aesthetics – A(H); Revance Therapeutics, Inc. – I(Grants/Research Funding); Rodan and Fields – A(H); Sciton Inc. – A(H), SP(H); Sienna Biopharmaceuticals – I(Grants/Research Funding); Ulthera – Data Safety Monitoring Board(H);
  • Saedi, Nazanin A., MD: Aerolase – I(EQ); Alastin Skincare, Inc – C(Fees); Cartessa Aesthetics – C(EQ); Cynosure, Inc – O(EQ);
  • Saluja, Sandeep, MD: no financial relationships exist with commercial interests.
  • Sawaya, Jennifer, MD: no financial relationships exist with commercial interests.
  • Stankiewicz, Kelly J., MD: Cutera, Inc. – I(H), SP(H);
  • Wanner, Molly, MD: Nuskin – A(Fees), C(Fees), I(Fees);
  • Wulkan, Adam, MD: no financial relationships exist with commercial interests.
Monday, March 4
1:00 PM
All faculty / Hands-on: Lasers
Event Details
  • Date
    Monday, March 4
  • Time
    1:00 PM - 4:00 PM
  • Location
    Room 143A
  • CME Credits
  • Type
  • Mathew M. Avram, MD, JD, FAAD
  • Arisa Ortiz, MD, FAAD
  • Adam Wulkan, MD, FAAD
  • Amanda Hope Champlain, MD
  • Catherine M DiGiorgio, MD, MS, FAAD
  • Eric F. Bernstein, MD, FAAD
  • Jennifer Sawaya, MD
  • Jeremy Green, MD, FAAD
  • Kachiu Cecilia Lee, MD, MPH, FAAD
  • Kelly J. Stankiewicz, MD, FAAD
  • Kristen Marie Kelly, MD, FAAD
  • Molly Wanner, MD, FAAD
  • Nazanin A. Saedi, MD, FAAD
  • Oge C. Onwudiwe, MD, FAAD
  • Sandeep Saluja, MD, FAAD
  • Suzanne L. Kilmer, MD, FAAD
  • Yakir S Levin, MD, PhD, FAAD